These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35878719)

  • 1. Spatio-Temporal Alterations in Synaptic Density During Epileptogenesis in the Rat Brain.
    Mikkelsen JD; Aripaka SS; Bascuñana P; Bankstahl M; Bankstahl JP; Pazarlar BA
    Neuroscience; 2022 Sep; 499():142-151. PubMed ID: 35878719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of synaptic vesicle protein 2A after status epilepticus and during epilepsy in a lithium-pilocarpine model.
    Contreras-García IJ; Pichardo-Macías LA; Santana-Gómez CE; Sánchez-Huerta K; Ramírez-Hernández R; Gómez-González B; Rocha L; Mendoza Torreblanca JG
    Epilepsy Behav; 2018 Nov; 88():283-294. PubMed ID: 30336420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal and spatial changes in synaptic vesicle glycoprotein 2A (SV2A) under kainic acid induced epileptogenesis: An autoradiographic study.
    Pazarlar BA; Madsen CA; Oyar EÖ; Eğilmez CB; Mikkelsen JD
    Epilepsy Res; 2022 Jul; 183():106926. PubMed ID: 35526328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal degeneration is observed in multiple regions outside the hippocampus after lithium pilocarpine-induced status epilepticus in the immature rat.
    Scholl EA; Dudek FE; Ekstrand JJ
    Neuroscience; 2013 Nov; 252():45-59. PubMed ID: 23896573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of synaptic density and cognitive performance in temporal lobe epilepsy: Humans and animals PET imaging study with [
    Xiao L; Xiang S; Chen C; Zhu H; Zhou M; Tang Y; Feng L; Hu S
    Psychiatry Clin Neurosci; 2024 Aug; 78(8):456-467. PubMed ID: 38804583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy.
    van Vliet EA; Aronica E; Redeker S; Boer K; Gorter JA
    Epilepsia; 2009 Mar; 50(3):422-33. PubMed ID: 18717715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo imaging of synaptic SV2A protein density in healthy and striatal-lesioned rats with [11C]UCB-J PET.
    Thomsen MB; Jacobsen J; Lillethorup TP; Schacht AC; Simonsen M; Romero-Ramos M; Brooks DJ; Landau AM
    J Cereb Blood Flow Metab; 2021 Apr; 41(4):819-830. PubMed ID: 32538280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombinant protein.
    Gillard M; Chatelain P; Fuks B
    Eur J Pharmacol; 2006 Apr; 536(1-2):102-8. PubMed ID: 16556440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Commonalities and differences in extracellular levels of hippocampal acetylcholine and amino acid neurotransmitters during status epilepticus and subsequent epileptogenesis in two rat models of temporal lobe epilepsy.
    Meller S; Brandt C; Theilmann W; Klein J; Löscher W
    Brain Res; 2019 Jun; 1712():109-123. PubMed ID: 30703372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Role of Synaptic Vesicle Glycoprotein 2A (SV2A) in Modulating Epileptogenesis.
    Ohno Y; Tokudome K
    CNS Neurol Disord Drug Targets; 2017; 16(4):463-471. PubMed ID: 28393712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single dose of cocaine raises SV2A density in hippocampus of adolescent rats.
    Rossi R; Bærentzen SL; Thomsen MB; Real CC; Wegener G; Grassi-Oliveira R; Gjedde A; Landau AM
    Acta Neuropsychiatr; 2024 Apr; 36(2):109-117. PubMed ID: 36847240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intranasal and oral administration of levetiracetam on the temporal and spatial distributions of SV2A in the KA-induced rat model of SE.
    Zhao W; Li Y; Sun H; Zhang W; Li J; Jiang T; Jiang L; Meng H
    J Cell Mol Med; 2023 Dec; 27(24):4045-4055. PubMed ID: 37845841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring with [
    Serrano ME; Bahri MA; Becker G; Seret A; Germonpré C; Lemaire C; Giacomelli F; Mievis F; Luxen A; Salmon E; Rogister B; Raedt R; Plenevaux A
    Mol Imaging Biol; 2020 Oct; 22(5):1197-1207. PubMed ID: 32206990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low distribution of synaptic vesicle protein 2A and synaptotagimin-1 in the cerebral cortex and hippocampus of spontaneously epileptic rats exhibiting both tonic convulsion and absence seizure.
    Hanaya R; Hosoyama H; Sugata S; Tokudome M; Hirano H; Tokimura H; Kurisu K; Serikawa T; Sasa M; Arita K
    Neuroscience; 2012 Sep; 221():12-20. PubMed ID: 22766234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of the monoacylglycerol lipase (MAGL) radiotracer [
    Mikkelsen JD; Aripaka SS; Egilmez CB; Pazarlar BA
    Neurochem Int; 2024 May; 175():105717. PubMed ID: 38447759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced synaptic vesicle protein 2A binding in temporal lobe epilepsy: A [
    Finnema SJ; Toyonaga T; Detyniecki K; Chen MK; Dias M; Wang Q; Lin SF; Naganawa M; Gallezot JD; Lu Y; Nabulsi NB; Huang Y; Spencer DD; Carson RE
    Epilepsia; 2020 Oct; 61(10):2183-2193. PubMed ID: 32944949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis and pharmacology of epilepsy in the lithium-pilocarpine model.
    André V; Dubé C; François J; Leroy C; Rigoulot MA; Roch C; Namer IJ; Nehlig A
    Epilepsia; 2007; 48 Suppl 5():41-7. PubMed ID: 17910580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease Postmortem.
    Bertoglio D; Verhaeghe J; Wyffels L; Miranda A; Stroobants S; Mrzljak L; Dominguez C; Skinbjerg M; Bard J; Liu L; Munoz-Sanjuan I; Staelens S
    J Nucl Med; 2022 Jun; 63(6):942-947. PubMed ID: 34531262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in the Properties of the Rat Hippocampus Glutamatergic System in the Lithium-Pilocarpine Model of Temporal Lobe Epilepsy.
    Diespirov GP; Postnikova TY; Griflyuk AV; Kovalenko AA; Zaitsev AV
    Biochemistry (Mosc); 2023 Mar; 88(3):353-363. PubMed ID: 37076282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression profile of synaptic vesicle glycoprotein 2A, B, and C paralogues in temporal neocortex tissue from patients with temporal lobe epilepsy (TLE).
    Pazarlar BA; Aripaka SS; Petukhov V; Pinborg L; Khodosevich K; Mikkelsen JD
    Mol Brain; 2022 May; 15(1):45. PubMed ID: 35578248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.